cequa
(cyclosporine)Sun Pharmaceutical Industries, Inc.
Usage: CEQUA ophthalmic solution is indicated for increasing tear production in patients with keratoconjunctivitis sicca (dry eye) as a calcineurin inhibitor immunosuppressant.
6 results
cyclosporine
(CYCLOSPORINE)Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.Usage: Cyclosporine capsules (modified) are indicated for preventing organ rejection in kidney, liver, and heart transplants. They also treat severe rheumatoid arthritis inadequately responding to methotrexate and manage severe, recalcitrant plaque psoriasis in nonimmunocompromised adults who have not responded to other systemic therapies.lupkynis
(Voclosporin)Aurinia Pharma U.S., Inc.Usage: LUPKYNIS is indicated for the treatment of adult patients with active lupus nephritis (LN) in combination with a background immunosuppressive therapy. Its safety and efficacy have not been established with cyclophosphamide, and its use in this context is not recommended.neoral
(cyclosporine)Novartis Pharmaceuticals CorporationUsage: Neoral is indicated for the prophylaxis of organ rejection in kidney, liver, and heart transplants, treatment of severe active rheumatoid arthritis unresponsive to methotrexate, and treatment of severe plaque psoriasis in adults who have not responded to other systemic therapies.restasis
(cyclosporine)Allergan, Inc.Usage: RESTASIS® ophthalmic emulsion is indicated for increasing tear production in patients with keratoconjunctivitis sicca, whose tear production is likely suppressed due to ocular inflammation. It is not effective in patients currently using topical anti-inflammatory drugs or punctal plugs.sandimmune
(cyclosporine)Novartis Pharmaceuticals CorporationUsage: Sandimmune (cyclosporine) is indicated for preventing organ rejection in kidney, liver, and heart transplants, to be used with adrenal corticosteroids. It may also treat chronic rejection in patients previously on other immunosuppressants. Injection form is reserved for patients who cannot take oral formulations due to anaphylaxis risk.